The Global Alzheimer's Platform (GAP) is a non-profit organization dedicated to speeding the delivery of innovative therapies to those afflicted with Alzheimer's by reducing the time and cost of Alzheimer’s disease (AD) clinical trials.
Their network of over 90 clinical trial sites across North America share knowledge and experience in order to effectively and efficiently work toward research progress in neurodegenerative conditions.
BrainHealth is proud to partner with Global Alzheimer's Platform to help place patients in clinical trials that match their biomarker profiles.
Learn more about Global Alzheimer's Platform.
Read more about clinical trials.